艾美捷科技代理G-Biosciences品牌。

G-Biosciences是一家专注于蛋白质组学研究的美国公司，产品广泛应用于学术研究和工业制造领域，包括：蛋白质检测、样品制备、电泳、蛋白质印迹、质谱、测定开发、抗体生产和蛋白质

纯化等。目前，G-Biosciences的高品质产品已经被超过25,000篇文章引用，并且这个数据还是不断增加。

G-Biosciences旨在提供试剂、特殊化学品、缓冲液、分析、应用试剂盒等各类研究工具；G-Biosciences还可以提供符合生物技术行业cGMP要求产品、高质量的定制和OEM制造。目前厂家

已经通过美国ISO9001：2015认证。

G-Biosciences公司产品包括：

（1）蛋白质组学：完整的蛋白质组学产品组合，包括蛋白质提取、分离和蛋白质色谱，到蛋白质标记和缀合和随后的蛋白质检测（蛋白质印迹和质谱）

（2）生物测定：用于测定开发和蛋白质检测的广泛的抗体、重组蛋白和ELISA库。细胞健康检测、SAM甲基转移酶、蛋白酶、磷酸酶和报告基因检测。

（3）DNA和RNA：大量基因组DNA和质粒DNA提取产品可供选择。RNA分离和净化试剂。经济实惠的PCR试剂，包括Taq和dNTPS。酵母DNA分离和转化试剂盒。

Cayman Chemical向全球科学工作者提供多研究领域的生化、免疫试剂和分析试剂盒，其产品被广泛应用于肿瘤、氧化氮、神经学、凋亡、氧化性损伤、内分泌学等不同研究领域。Cayman Chemical可提供用于检测的特色试剂盒，如：类花生酸类物质、游离的生物标志、环核苷、激素及氧化氮等；也提供多种高质量试剂，包括：类花生酸类物质、氧化氮试剂及许多相关脂质、脂肪酸、酶和抗体。"

Cayman Chemical Company is an American biotechnology company founded in 1980, headquartered in Ann Arbor, MI. The company provides chemicals that are used primarily by universities and pharmaceutical companies for research and the development of medicines. The company is also known as a provider of reference standards to state and federal crime labs for use in the detection of rapidly evolving designer drugs. Small quantities of these known reference standards are analyzed using mass spectrometry and gas chromatography techniques to match against forensic evidence, usually confiscated by law enforcement, or forensic toxicological evidence collected in the form of biological samples such as urine, blood, or tissue.

Cayman chemical的主要产品包括：

Chemical Analysis

Chemical Synthesis

Bioanalysis

Medicinal Chemistry

Prostaglandin APIs

R&D Services

Manufacturing

Biochemicals

Assay Kits

Antibodies

Proteins

Analytical Standards

Certified Reference Materials

艾美捷科技特约代理Avidity Biosciences公司产品。

Avidity Biosciences公司位于美国加州La Jolla，是一家专门从事抗体寡核苷酸结合物（AOC™）技术开发的生物技术公司，此项技术结合了单抗组织选择性和寡核苷酸疗法的精确性，克服了寡核苷酸给药屏障。

Avidity Biosciences is a privately-held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC™). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

Antibody oligonucleotide conjugate (AOC™) technology

Avidity’s antibody oligonucleotide conjugate (AOC™) technology utilizes antibodies to target cells and tissues of interest and facilitate the uptake and internalization of oligonucleotide payloads. By combining the cellular and tissue selectivity of antibodies with the selectivity and efficiency of oligo-based approaches, Avidity has demonstrated modulation of disease-related RNAs in diverse cell types and tissues including muscle, heart, liver, tumors and immune cells.